Catalyst Pharmaceuticals, Inc. (CPRX) SEC Filings — 2024
25 SEC filings for Catalyst Pharmaceuticals, Inc. (CPRX) in 2024.
Filings
- Catalyst Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Catalyst Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 8, 2024
- Catalyst Pharmaceuticals Files 8-K — 8-K · Nov 6, 2024
- Catalyst Pharma Q3: Strong Royalties, Capital Gains — 10-Q · Nov 6, 2024
- Catalyst Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Oct 18, 2024
- Catalyst Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Oct 17, 2024
- Catalyst Pharma to Acquire New Product — 8-K · Sep 26, 2024
- Catalyst Pharmaceuticals Files 8-K — 8-K · Aug 7, 2024
- Catalyst Pharma Q2 Revenue Up, Acquires FYCOMPA Rights — 10-Q · Aug 7, 2024
- Catalyst Pharma Acquires Firdapse Rights — 8-K · Jul 26, 2024
- Catalyst Pharmaceuticals Files 8-K — 8-K · May 30, 2024
- Catalyst Pharma Unveils New Equity Incentive Plan — 8-K · May 21, 2024
- Catalyst Pharma Q1: FYCOMPA® Distribution Shift, Santhera Payment Complete — 10-Q · May 8, 2024
- Catalyst Pharmaceuticals, Inc. files DEF 14A Proxy Statement — DEF 14A · Apr 10, 2024
- Catalyst Pharmaceuticals Files 8-K — 8-K · Mar 13, 2024
- Catalyst Pharma Files Routine 8-K, No New Material Events — 8-K · Feb 29, 2024
- Catalyst Pharmaceuticals, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 28, 2024
- Catalyst Pharma Files 8-K on Other Events and Exhibits — 8-K · Feb 21, 2024
- Catalyst Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Deerfield Mgmt Exits Catalyst Pharma (CPRX) Position — SC 13G/A · Feb 12, 2024
- State Street Amends Passive Stake in Catalyst Pharma — SC 13G/A · Jan 25, 2024
- BlackRock Amends Catalyst Pharma Stake (SC 13G/A) — SC 13G/A · Jan 22, 2024
- Catalyst Pharma Files 8-K, Confirms NASDAQ Listing — 8-K · Jan 9, 2024
- Catalyst Pharma Confirms NASDAQ Listing in 8-K Filing — 8-K · Jan 8, 2024
- Catalyst Pharma Files 8-K on Material Agreement; Details Pending — 8-K · Jan 5, 2024